Cystitis (Bladder Infection) Prevention and Support Protocol

Cystitis is inflammation of the bladder, usually caused by a bacterial infection (urinary tract infection or UTI). It's very common, especially in women, with about 50% of women experiencing at least one UTI in their lifetime.

SYMPTOMS of cystitis:

•Burning sensation when urinating

•Frequent urge to urinate

•Passing small amounts of urine

•Cloudy or strong-smelling urine

•Blood in urine

•Pelvic discomfort

•Low-grade fever

RISK FACTORS:

•Female anatomy (short urethra)

•Sexual activity

•Menopause

•Urinary retention

•Catheter use

•Diabetes

CRITICAL: Acute cystitis typically requires antibiotic treatment. See a doctor for proper diagnosis and treatment.

WHEN TO SEEK IMMEDIATE CARE:

•Fever or chills

•Back or side pain (may indicate kidney infection)

•Nausea or vomiting

•Blood in urine

•Symptoms not improving with antibiotics

PREVENTION STRATEGIES:

•Drink plenty of fluids

•Urinate frequently (don't hold it)

•Wipe front to back

•Urinate after sexual activity

•Avoid irritating products

* D-Mannose has strong evidence for preventing recurrent UTIs - it prevents E. coli from sticking to the bladder wall.

* Cranberry products with adequate PACs (proanthocyanidins) may help prevent recurrence.

* Probiotics (specific Lactobacillus strains) support healthy urogenital flora.

Expected timeline: Acute symptoms typically improve within 1-3 days of starting antibiotics. Prevention supplements should be taken ongoing for those with recurrent infections.

Clinical Perspective

Cystitis/UTI: Most commonly caused by E. coli (80-90%). Uncomplicated cystitis in women: straightforward treatment. Complicated UTI: pregnancy, male, structural abnormality, catheter, immunocompromised. Recurrent UTI: >=3 per year or >=2 in 6 months. Diagnosis: urinalysis, urine culture for complicated or treatment failure.

CRITICAL: Acute cystitis requires antibiotics (nitrofurantoin, TMP-SMX, fosfomycin). Supplements are for PREVENTION of recurrence, not treatment of acute infection. D-mannose and cranberry have best evidence for prevention. Consider prophylactic antibiotics for frequent recurrence. Rule out complicated UTI (pyelonephritis, structural issues).

* D-Mannose (A-grade): Anti-adhesion. RCT: (PMID: 24276074). 1.5-2g daily prevention. As effective as antibiotics in trial.

* Cranberry (B-grade): Anti-adhesion; PAC content matters. Cochrane: (PMID: 28696087). 36mg PACs or 400-500mg extract daily.

* Probiotics (B-grade): Vaginal flora. Systematic review: (PMID: 29882905). L. rhamnosus GR-1, L. reuteri RC-14. 1-10 billion CFU daily.

* Vitamin C (C-grade): Urine acidification. Review: (PMID: 23075608). 500-1000mg daily. Limited evidence.

* Uva Ursi (C-grade): Antimicrobial. Systematic review: (PMID: 26182896). Short-term only. Hydroquinone toxicity risk.

* Vitamin D (C-grade): Antimicrobial peptides. Review: (PMID: 28750270). 2000-4000 IU daily.

Assessment targets: Urinalysis, culture if indicated, symptom resolution, recurrence frequency.

Protocol notes: Prevention more effective than treatment focus. Hydration: essential; dilutes bacteria, promotes urination. Post-coital voiding: reduces risk in sexually active women. Post-menopausal: vaginal estrogen reduces recurrence; consider for prevention. Prophylactic antibiotics: low-dose continuous or post-coital for frequent recurrence. D-mannose: most promising supplement; works by preventing bacterial adhesion; E. coli specific. Cranberry: product matters; needs adequate PAC content; juice often insufficient. Interstitial cystitis: different condition (painful bladder syndrome); not infectious; chronic management. Asymptomatic bacteriuria: don't treat except in pregnancy. Male UTI: consider complicated; evaluate for prostatitis, structural issues. Elderly: may present atypically; confusion, falls. Catheter-associated: common; asymptomatic colonization expected; treat symptoms.

View All Protocols